Disease Info Card

Paraganglioma

Information about Paraganglioma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Paraganglioma

Most recent studies have shown that Paraganglioma shares some biological mechanisms with adenoma, adrenal-gland-neoplasms, carcinoid-tumor, carcinoma, carotid-body-paraganglioma, extra-adrenal-paraganglioma, glomus-jugulare-tumor, head-and-neck-neoplasms, hemorrhage, hypertensive-disease, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasm-metastasis, neoplasms, neoplasms-multiple-primary, neuroendocrine-tumors, pain, pheochromocytoma, retroperitoneal-neoplasms, von-hippel-lindau-syndrome.

Among the many pathways, these few ones have gauged particular interests from scientists studying Paraganglioma, and have been seen in publications frequently: Angiogenesis, Catecholamine Secretion, Cell Proliferation, Electron Transport, Electron Transport Chain, Excretion, Glycolysis, Hormone Secretion, Innervation, Localization, Methylation, Micturition, Oncogenesis, Oxidative Phosphorylation, Pathogenesis, Secretion, Transport, Transposition, Tricarboxylic Acid Cycle

Quite a number of genes have been found to play important roles in Paraganglioma, such as ENO1, ENO2, GFAP, NF1, POMC, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, SDS, SDSL, SS18L1, SST, SYP, VHL. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.

Paraganglioma Related Genes

click to see detail information for each gene

ENO1 ENO2 GFAP
NF1 POMC RET
SDHA SDHAF2 SDHB
SDHC SDHD SDS
SDSL SS18L1 SST
SYP VHL